# ðŸ©º Elite Trading System: The Ultimate Quant Autopsy Report

### **Dissecting the Truth Behind Priority Top 5 Models**
Rigorous simulation across the most recent 800 15m candles to break the strategy apart. We enforce strict parameters: **10x Leverage**, **0.1% Comms**, **0.05% Slippage**, and **0.01%/8h Funding Simulation**. If they survive this, they survive anything.

## ðŸ“Š Aggregate Backtest Metrics

| Strategy                | Pair     | ROI     |   Sharpe | Max DD   | Win %   |   Profit Factor |   Trades |
|-------------------------|----------|---------|----------|----------|---------|-----------------|----------|
| GRID_5_0.005            | INJ/USDT | 8.38%   |     2.72 | 6.18%    | 48.30%  |            1.84 |      147 |
| SCALP_RSI14_BB20_ATR2.0 | INJ/USDT | 150.40% |     3.7  | 63.51%   | 16.39%  |            1.19 |       61 |
| GRID_5_0.005            | ETH/USDT | 1.98%   |     2.2  | 2.70%    | 46.67%  |            1.12 |      255 |
| BB_20_2.0               | INJ/USDT | 235.30% |     4.27 | 59.11%   | 23.40%  |            1.72 |       47 |
| MACD_12_26_9            | BIO/USDT | 233.21% |     4.91 | 86.35%   | 0.00%   |            0    |       44 |

## ðŸŽ² Risk Analysis: Monte Carlo Path Simulations (100x)
*By heavily shuffling return trajectories, we simulate stress tests showing what extreme path vulnerability (sequence of returns risk) they carry.*

| Strategy                | Pair     | 95% VaR (Max DD)   | Median MC DD   |
|-------------------------|----------|--------------------|----------------|
| GRID_5_0.005            | INJ/USDT | 10.01%             | 6.68%          |
| SCALP_RSI14_BB20_ATR2.0 | INJ/USDT | 72.30%             | 59.77%         |
| GRID_5_0.005            | ETH/USDT | 4.26%              | 2.53%          |
| BB_20_2.0               | INJ/USDT | 70.60%             | 55.06%         |
| MACD_12_26_9            | BIO/USDT | 89.53%             | 77.54%         |

## ðŸ“ˆ The Anatomy: Visual Diagnostics

### Cumulative Equity Curves
![Equity curves generated](equity.png)

### Performance Heatmap Matrix
![Heatmap generated](heatmap.png)

## âš–ï¸ Surgeon's Final Recommendations
1. **Check the 95% VaR (Max Drawdown)** from the Monte Carlo runs. If a strategy's VaR breaks your 10% daily limit or poses a liquidation threat under 10x leverage, immediately reduce the capital allocation dynamically (leverage slider drop -> 5x).
2. **Paper Trade the Top Performer first.** You want to see execution mirroring these lines before commiting live equity.

